PO Box 1488
Warrenville, IL 60555
Phone: 331.248.7888
Email: sidp@affinity-strategies.com
Erin McCreary (@erinmccreary) and Ryan Shields (@ryankshields) discuss notable infectious diseases publications from the first half of 2020!
Papers discussed:
- Rybak MJ, et al. Am J Health Syst Pharm. 2020 May 19;77(11):835-864. doi: 10.1093/ajhp/zxaa036.
- Scheetz MH. Am J Health Syst Pharm. 2020 May 19;77(11):810-811. doi: 10.1093/ajhp/zxaa076.
- Alosaimy S, et al. Clin Infect Dis. 2020 July 27;ciaa1039. doi: 10.1093/cid/ciaa1039.
- Rhee C, et al. Clin Infect Dis. 2020 May 6;ciaa059. doi: 10.1093/cid/ciaa059.
- Heil EL, et al. Pharmacotherapy. 2020 Apr;40(4):368-371. doi: 10.1002/phar.2384.
- Townsend SR, et al. Clin Infect Dis. 2020 May 6;ciaa458. doi: 10.1093/cid/ciaa458.
- Satlin MJ, et al. Clin Infect Dis. 2020 Feb 13;ciaa121. doi: 10.1093/cid/ciaa121.
- Pogue JM, et al. Antimicrob Agents Chemother. 2020 Jan 27;64(2):e01495-19. doi: 10.1128/AAC.01495-19.
- Ambrose PG, et al. Open Forum Infect Dis. 2020 Mar 13;7(7):ofaa084. doi: 10.1093/ofid/ofaa084.
- Singh N, et al. JAMA. 2020 Apr 14;323(14):1378-1387. doi: 10.1001/jama.2020.3138.
- van Delden C, et al. Clin Infect Dis. 2020 Jan 9;ciz1113. doi: 10.1093/cid/ciz1113.
- Niederman MS, et al. Lancet Infect Dis. 2020 Mar;20(3):330-340. doi: 10.1016/S1473-3099(19)30574-2.
- von Dach E, et al. JAMA. 2020 Jun 2;323(21):2160-2169. doi: 10.1001/jama.2020.6348.
- Mergenhagen KA, et al. Antimicrob Agents Chemother. 2020 Feb 21;64(3):e02167-19. doi: 10.1128/AAC.02167-19.
For BCIDP credit, visit https://sidp.org/BCIDP
Erin McCreary, PharmD, BCIDP
Dr. McCreary is a Clinical Assistant Professor and ID Clinical Pharmacist at University of Pittsburgh Medical Center. She completed her Doctor of Pharmacy education at the Auburn University Harrrison School of Pharmacy then completed both her PGY1 and PGY2 ID residency at the University of Wisconsin Health. She has served as a member of the American Society for Microbiology Planning Committee and is the chair of the SIDP Publications Committee. Her areas of interest include infectious diseases and antimicrobial stewardship in immunocompromised hosts, antimicrobial resistance and antimicrobial pharmacokinetic/pharmacodynamic optimization.
Ryan Shields, PharmD, MS
Dr. Ryan Shields is an Associate Professor at the University of Pittsburgh. Dr. Shields completed his PGY1 residency at Saint Louis University Hospital followed by a PGY2 residency in Infectious Diseases at the University of Pittsburgh. Dr. Shields has an interest in research focused on antimicrobial drug resistance in gram-negative bacteria and yeast, use of molecular markers of resistance to predict patient responses to treatment, use of pharmacokinetic-pharmacodynamic models to suppress and overcome antimicrobial resistance, antimicrobial susceptibility testing methods, and the clinical impact of infections due to extensively-drug resistant pathogens.
